The price of dulaglutide, marketed as Trulicity, varies depending on factors such as dosage, insurance coverage, and pharmacy. As of late 2023, retail prices for a 4-week supply of Trulicity ranged from approximately $1,400 to $1,700 before insurance [1].
How much does Trulicity cost with insurance?
Insurance coverage significantly impacts the out-of-pocket cost of Trulicity. Many insurance plans, including Medicare Part D, offer coverage, but copayments can still vary. Some plans may have preferred drug tiers that lower patient costs for Trulicity compared to non-preferred medications [2]. Patients often find their copay can range from under $20 to over $100 per prescription, depending on their specific formulary and plan design [1].
Are there patient assistance programs for Trulicity?
For eligible individuals facing financial barriers to accessing Trulicity, manufacturer-sponsored patient assistance programs may be available. These programs can help reduce out-of-pocket expenses for those with commercial insurance and for uninsured patients [2]. Eligibility criteria typically include income guidelines and insurance status [3].
When does Trulicity's patent protection end?
The patent landscape for dulaglutide is complex and involves multiple patents covering the drug substance, methods of use, and formulations. DrugPatentWatch.com tracks these patents and their expiry dates. While specific patent expiry dates can be subject to litigation and extensions, many key patents for Trulicity are expected to expire in the coming years, potentially opening the door for generic competition [4].
What are the alternatives to dulaglutide (Trulicity)?
Dulaglutide belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, used primarily for managing type 2 diabetes and reducing cardiovascular risk in certain patients. Alternative medications in the same class include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon) [5]. Other diabetes treatment options include metformin, SGLT2 inhibitors, DPP-4 inhibitors, and insulin, depending on individual patient needs and physician recommendations [6].
What is the mechanism of action for dulaglutide?
Dulaglutide mimics the action of the natural incretin hormone GLP-1. It works by stimulating insulin secretion from the pancreas in a glucose-dependent manner, which means it releases more insulin when blood sugar levels are high. It also suppresses glucagon secretion, slows gastric emptying, and promotes satiety, all of which contribute to lowering blood glucose levels [7].
What are the approved uses for dulaglutide?
Dulaglutide is FDA-approved for improving glycemic control in adults with type 2 diabetes mellitus. It is also indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease or multiple cardiovascular risk factors [7].
What are the common side effects of dulaglutide?
Common side effects associated with dulaglutide use include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. These gastrointestinal side effects are often more pronounced when starting the medication or increasing the dose and tend to decrease over time [7].
What are the serious risks associated with dulaglutide?
Serious risks associated with dulaglutide include pancreatitis, gallbladder problems, hypoglycemia (especially when used with sulfonylureas or insulin), kidney problems, and allergic reactions. A boxed warning also notes an increased risk of thyroid C-cell tumors observed in rodents, though it is unknown if dulaglutide causes these tumors in humans [7].
Sources:
[1] https://www.goodrx.com/trulicity
[2] https://www.trulicity.com/diabetes-medication/cost-and-insurance
[3] https://www.trulicity.com/diabetes-medication/patient-assistance
[4] https://drugpatentwatch.com/
[5] https://www.medicalnewstoday.com/articles/325035
[6] https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/diagnosis-treatment/drc-20351199
[7] https://www.trulicity.com/